Human MDR gene transfer in patients with advanced cancer

Hum Gene Ther. 1994 Sep;5(9):1151-60. doi: 10.1089/hum.1994.5.9-1151.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / biosynthesis
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Diseases / chemically induced
  • Bone Marrow Diseases / therapy*
  • Bone Marrow Transplantation*
  • Cells, Cultured
  • Clinical Protocols
  • Combined Modality Therapy
  • Drug Resistance / genetics
  • Female
  • Gene Transfer Techniques*
  • Genetic Therapy* / adverse effects
  • Genetic Vectors
  • Hematopoietic Stem Cell Transplantation*
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Neoplasms / drug therapy
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Pilot Projects
  • Recombinant Fusion Proteins / biosynthesis
  • Remission Induction
  • Retroviridae / genetics
  • Safety

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Recombinant Fusion Proteins